Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth

HIV Clinical Trial

Official title:

Integrating Mental Health Into a HIV Clinic to Improve Outcomes Among Tanzanian Youth

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02888288
• Other study ID #: Pro00069892
• Status: Completed
• Phase: N/A
• Start date: July 2016
• Est. completion date: August 28, 2020

Study information

• Verified date: October 2022
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate if a group-based mental health intervention called Sauti ya Vijana (The Voice of Youth) designed to address mental health challenges faced by adolescents in Tanzania is acceptable and feasible and if it improves mental health, antiretroviral therapy (ART) adherence, and virologic outcomes among HIV-positive adolescents as compared to youth receiving treatment as usual. Mental health intervention sessions will take place three times a month for approximately four months in groups of eight to ten youth based on age and sex. Caregivers will attend two sessions to support the youth and provide the guardian perspective on caring for HIV-positive adolescents. The investigator hypothesizes the mental health intervention will be acceptable, feasible, and will improve mental health and ART adherence among participating youth and this improvement will be sustained over time.

Description:

The study will enroll up to approximately 130 participants from the established Kilimanjaro Christian Medical Centre and Mawenzi Saturday Teen Clinics. Participants will be assigned to approximately eight to ten persons per group, based on age and sex. Groups will be matched in pairs as closely as possible (ex. two groups of females 12-16 years of age) and assigned to Wave 1, 2, or 3. Randomization will occur on the individual level and will occur just before the start of mental health intervention for each wave. Individuals will be randomized at this time point to reduce potential drop out of those with delayed start (Wave 2/3). Randomization will occur by a coin flip for two individuals based on alphabetical order: heads will be intervention group (I) and tails the standard of care group (SOC).

This feasibility study is longitudinal with up to 24 month follow-up after intervention. Feasibility measures from lay counselors will be monitored weekly. Outcome measures will be obtained by blinded interviewers using a structured survey to inquire about mental health symptoms, self-report adherence, obtain an ART drug concentration level from a hair sample, and HIV-1 viral load from a blood sample and will be collected by the same research assistants at five to six potential time points: 1) baseline, 2) pre-intervention, 3) post-intervention, 4) 6-months post-intervention, 5) 12-months post-intervention and 6) 24-months post-intervention.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 140
• Est. completion date: August 28, 2020
• Est. primary completion date: August 28, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 24 Years

Eligibility

Inclusion Criteria:

• Youth between the ages of 12 and 24 years of age, attending the Teen Club HIV clinic at Kilimanjaro Christian Medical Centre (KCMC) and/or Mawenzi Hospital and receiving ART

• if > or =l to 18 years, able to understand the project and provide written, informed consent

• if < 18 years, a parent or guardian must provide written permission and participant must be able to assent

• all adolescents must also commit to attending 10 weekly CBT (SYV) sessions and 2 individual sessions.

Exclusion Criteria:

• Active psychosis, developmental delay, or cognitive disability that precludes active participation in consent process, intervention, and assessment interviews.

Related Conditions & MeSH terms

• Health Behavior
• HIV
• Mental Health

Intervention

Behavioral:
• Mental Health Intervention
Includes a standard format of greetings, review of last session content, homework discussion, new topic, assigning homework and ends with a fun activity, relaxation or game. First session is a joint session with youth and caregivers. Topics include common stresses and worries experienced by HIV+ youth; relaxation and coping techniques; cognitive behavioral triangle; story of finding out HIV status and if willing, to discuss this in an individual session, peer group session, and with caregiver; identify circles of support; discuss stigma and how to disclose HIV status to others; consider values, hopes and dreams for the future, and how to use this information to live positively with HIV. ART adherence is woven into case examples and discussions.
• Standard of Care
Standard of Care includes enhanced ART adherence based on clinic protocols and monthly HIV teaching sessions prior to adolescent clinic.

Locations

Country	Name	City	State
Tanzania	Kilimanjaro Christian Medical Centre	Moshi

Sponsors (2)

Lead Sponsor	Collaborator
Duke University	Kilimanjaro Christian Medical Centre, Tanzania

Country where clinical trial is conducted

Tanzania, 

References & Publications (3)

Dow DE, Turner EL, Shayo AM, Mmbaga B, Cunningham CK, O'Donnell K. Evaluating mental health difficulties and associated outcomes among HIV-positive adolescents in Tanzania. AIDS Care. 2016 Jul;28(7):825-33. doi: 10.1080/09540121.2016.1139043. Epub 2016 Feb 3. — View Citation

Gichane MW, Sullivan KA, Shayo AM, Mmbaga BT, O' Donnell K, Cunningham CK, Dow DE. Caregiver role in HIV medication adherence among HIV-infected orphans in Tanzania. AIDS Care. 2018 Jun;30(6):701-705. doi: 10.1080/09540121.2017.1391986. Epub 2017 Oct 23. — View Citation

Ramaiya MK, Sullivan KA, O' Donnell K, Cunningham CK, Shayo AM, Mmbaga BT, Dow DE. A Qualitative Exploration of the Mental Health and Psychosocial Contexts of HIV-Positive Adolescents in Tanzania. PLoS One. 2016 Nov 16;11(11):e0165936. doi: 10.1371/journal.pone.0165936. eCollection 2016. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Participant attendance	Measure the percentage of participants who complete all intervention sessions and ability to interview participants for outcome measures over time.	weekly for 16 weeks during each intervention wave (over 2 years)
Primary	Caregiver participation as measured by questionnaire	Record willingness of caregivers to participate (if unwilling, why not) and attendance.	during 2 caregiver sessions
Primary	Caregiver participation as measured by attendance sheet		during 2 caregiver sessions
Primary	Fidelity as measured by weekly supervisor meeting		weekly for 16 weeks during the intervention wave (over 2 years)
Primary	Fidelity as measured by fidelity checklists		weekly for 16 weeks during the intervention wave (over 2 years)
Secondary	Change in Mental Health	Compare the change in standard deviation of mental health symptoms on the PHQ-9, between the intervention group versus SOC.	pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Secondary	Change in Mental Health	Compare the change in standard deviation of mental health symptoms on the SDQ, between the intervention group versus SOC.	pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Secondary	Change in Mental Health	Compare the change in standard deviation of mental health symptoms on the UCLA PTSD-RI, between the intervention group versus SOC.	pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Secondary	Change in ART adherence	Compare the change in self-report adherence between the intervention group versus SOC.	pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Secondary	Change in virologic outcomes	Describe the proportion of youth with viral suppression (HIV-1 RNA < 400 copies/ml) in the intervention group and SOC.	pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Secondary	Compare method of adherence measurement	Compare self-report ART adherence with drug level concentration of hair samples.	pre-intervention, within 1 month post-intervention, 6- and 12- months post-intervention
Secondary	Change in mental health (individual)	Compare the change in standard deviation of mental health symptoms on the PHQ-9, SDQ, UCLA PTSD-RI at the individual level.	baseline to post-intervention, 6-, 12-,18- and 24-months
Secondary	Change in adherence (individual)	Compare the change in self-reported adherence and antiretroviral drug concentration in hair.	baseline to post-intervention, 6-, 12-, and 24-months
Secondary	Change in HIV viral load (individual)	Compare the change in HIV viral load.	baseline to post-intervention, 6-, 12-, and 24-months